321 related articles for article (PubMed ID: 28657191)
1. Intended and unintended use of cathinone mixtures.
Guirguis A; Corkery JM; Stair JL; Kirton SB; Zloh M; Schifano F
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657191
[TBL] [Abstract][Full Text] [Related]
2. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
3. The effects and toxicity of cathinones from the users' perspectives: A qualitative study.
Assi S; Gulyamova N; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631397
[TBL] [Abstract][Full Text] [Related]
4. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
German CL; Fleckenstein AE; Hanson GR
Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
[TBL] [Abstract][Full Text] [Related]
5. The clinical challenges of synthetic cathinones.
Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
[TBL] [Abstract][Full Text] [Related]
6. A narrative review of the neuropharmacology of synthetic cathinones-Popular alternatives to classical drugs of abuse.
Kuropka P; Zawadzki M; Szpot P
Hum Psychopharmacol; 2023 May; 38(3):e2866. PubMed ID: 36866677
[TBL] [Abstract][Full Text] [Related]
7. Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").
Riley AL; Nelson KH; To P; López-Arnau R; Xu P; Wang D; Wang Y; Shen HW; Kuhn DM; Angoa-Perez M; Anneken JH; Muskiewicz D; Hall FS
Neurosci Biobehav Rev; 2020 Mar; 110():150-173. PubMed ID: 31101438
[TBL] [Abstract][Full Text] [Related]
8. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
Tyrkkö E; Andersson M; Kronstrand R
Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
[TBL] [Abstract][Full Text] [Related]
9. Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).
Grifell M; Ventura M; Carbón X; Quintana P; Galindo L; Palma Á; Fornis I; Gil C; Farre M; Torrens M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657185
[TBL] [Abstract][Full Text] [Related]
10. [Cathinones use in Paris].
Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S
Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479
[TBL] [Abstract][Full Text] [Related]
11. The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.
Karila L; Billieux J; Benyamina A; Lançon C; Cottencin O
Brain Res Bull; 2016 Sep; 126(Pt 1):61-67. PubMed ID: 26995278
[TBL] [Abstract][Full Text] [Related]
12. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
13. 4F-PBP (4'-fluoro-α-pyrrolidinobutyrophenone), a new substance of abuse: Structural characterization and purity NMR profiling.
Gaspar H; Bronze S; Ciríaco S; Queirós CR; Matias A; Rodrigues J; Oliveira C; Cordeiro C; Santos S
Forensic Sci Int; 2015 Jul; 252():168-76. PubMed ID: 26005857
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
Sande M
Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
[TBL] [Abstract][Full Text] [Related]
15. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cathinones ("bath salts").
Banks ML; Worst TJ; Rusyniak DE; Sprague JE
J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cathinone adulteration of illegal drugs.
Oliver CF; Palamar JJ; Salomone A; Simmons SJ; Philogene-Khalid HL; Stokes-McCloskey N; Rawls SM
Psychopharmacology (Berl); 2019 Mar; 236(3):869-879. PubMed ID: 30338489
[TBL] [Abstract][Full Text] [Related]
18. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cathinones: a new public health problem.
Karila L; Megarbane B; Cottencin O; Lejoyeux M
Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
[TBL] [Abstract][Full Text] [Related]
20. Bath salts and polyconsumption: in search of drug-drug interactions.
Lopez-Rodriguez AB; Viveros MP
Psychopharmacology (Berl); 2019 Mar; 236(3):1001-1014. PubMed ID: 30911791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
